Envoys from various countries reach Hyderabad for briefing on development of COVID vaccine

Bharat Biotech is working on its vaccine Covaxin which will be an inactivated vaccine presently in the third stage of trials. Biological E is also in the human trials stage.

Published: 09th December 2020 02:21 PM  |   Last Updated: 09th December 2020 02:25 PM   |  A+A-

The delegates began their trip by visiting two institutions -- Biological E and Bharat Biotech -- in Genome Valley (Photo | Special arrangement)

By Express News Service

HYDERABAD: Nearly 60 delegates from various countries landed at the RGIA Airport in Hyderabad on Wednesday morning to kickstart their India tour to look into the development of key COVID-19 vaccines being made here.

The delegates began their trip by visiting two institutions -- Biological E and Bharat Biotech -- in Genome Valley.

The delegation includes Ambassadors and High Commissioners of various countries who after their visit to Hyderabad will visit other cities to find out about the vaccines being made there.

Bharat Biotech is working on its vaccine Covaxin which will be an inactivated vaccine presently in the third stage of trials. Biological E is also in the human trials stage.

In all, there are three vaccines in India in the third stage of development, piquing the interest of the world at the country's capacity.


Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.